Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children

L Agertoft, S Pedersen - Respiratory medicine, 1994 - Elsevier
In a controlled prospective study we have measured growth and pulmonary function in
children with asthma during long-term treatment with inhaled budesonide and compared these …

[HTML][HTML] Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy

…, R Klink, EM Varga, I Huttegger, L Agertoft… - Journal of Allergy and …, 2018 - Elsevier
… are calculated based on the estimated coefficients (coef) in the GLMM: R R R = 1 − R R =
e c o e f _ G r a z a x 1 + e c o e f _ G r a z a x e c o e f _ P l a c e b o 1 + e c o e f _ P l a c e b o …

Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation

…, G Greisen, B Robertson, A Bertelsen, L Agertoft… - …, 1999 - publications.aap.org
Objective. To determine whether early versus late treatment with porcine surfactant (Curosurf)
reduces the requirement of mechanical ventilation in very preterm infants primarily …

[HTML][HTML] Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

L Agertoft, S Pedersen - New England Journal of Medicine, 2000 - Mass Medical Soc
Background Short-term studies have shown that inhaled corticosteroids may reduce the
growth of children with asthma. However, the effect of long-term treatment on adult height is …

Surfaktantbehandling af nyfødte med respiratorisk distress-syndrom primaert behandlet med nasalt kontinuerligt positivt luftvejstryk. En pilotundersøgelse

H Verder, L Agertoft, P Albertsen, T Curstedt… - Ugeskrift for …, 1992 - research.regionh.dk
In this pilot study, Curosurf (200 mg/kg) was administrated to 34 patients with the respiratory
distress syndrome in nasal-CPAP therapy with FiO2 requirements greater than 0.60 and/or …

Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study

H Verder, L Agertoft, P Albertsen… - Ugeskrift for …, 1992 - europepmc.org
In this pilot study, Curosurf (200 mg/kg) was administrated to 34 patients with the respiratory
distress syndrome in nasal-CPAP therapy with FiO2 requirements greater than 0.60 and/or …

Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide

L AGERTOFT, S PEDERSEN - American journal of respiratory and …, 1998 - atsjournals.org
The aim of our study was to assess the effects of long-term treatment with inhaled budesonide
(BUD) on total body bone mineral density (BMD), total body bone mineral capacity (BMC), …

Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study.

S Husby, L Agertoft, S Mortensen… - Archives of disease in …, 1993 - adc.bmj.com
The aim of this prospective, randomised, double blind study was to evaluate whether nebulised
local steroid treatment is effective in the treatment of croup. Thirty six infants and children …

Importance of the inhalation device on the effect of budesonide.

L Agertoft, S Pedersen - Archives of Disease in Childhood, 1993 - adc.bmj.com
Two hundred and forty one children with chronic perennial asthma, who had been treated
with budesonide via a metered dose inhaler with a spacer device (Nebuhaler), had their …

Catch-up growth, rapid weight growth, and continuous growth from birth to 6 years of age in very-preterm-born children

LH Toftlund, S Halken, L Agertoft, G Zachariassen - Neonatology, 2018 - karger.com
Background: Breastfeeding promotes healthy growth in very-preterm-born infants (VPI), but
extra nutritional supply is needed to ensure catch-up growth and brain development. …